International

Latest immunisation news from around the world

27 Feb 2014
His efforts to improve child health in Northland have been recognised with the 2014 Kiwibank New Zealander of the Year award. O'Sullivan and his wife Tracy set up the low-cost health clinic Te Kohhunga Whakaora ("The Nest of Wellness"). O'Sullivan has also been instrumental in establishing Manawa Ora Korokoro Ora (Moko) programme, the first...
21 Nov 2013
The story claimed that one of the investigators involved in the clinical trials for Gardasil (Dr Diane Harper) had spoken out against the human papillomavirus vaccine Gardasil. Harper denied the claims made by the Daily Express, asserting that her criticism was about marketing of the vaccine in the United States not the safety of the vaccine. Not...
29 Oct 2013
The World Health Organization (WHO) have reported a cluster of 22 cases of acute flaccid paralysis with laboratory investigation of 10 of these cases identifying wild poliovirus type 1. Most of the cases are children under two years of age who were unimmunised or had not completed their primary course of polio immunisations.  The WHO identifies...
15 Aug 2013
The next steps will involve the Australian Technical Advisory Group on Immunisation making recommendations of who should receive the vaccine on the National Immunisation Programme to the Minister for Health and Ageing, and Novartis working with regulatory authorities to make the vaccine available for private purchase in Australia. Meningococcal...
27 Mar 2013
The book, published in January 2013, is based on infromation provided by the HistoryofVaccines.org website which is well worth a visit even if only to watch the animated timeline showing the history of diseases, epidemics, vaccine discovery and development and public health measures to protect people against disease. The book is only available...
25 Jan 2013
In Europe, the vaccine has been licensed for use in individuals two months of age and older. The Therapeutic Goods Administration (TGA) in Australia is also reviewing the vaccine data and considering licensure of Bexsero® in Australia. Bexsero® will complement the currently available meningococcal group C and groups A, C, Y and W-135 vaccines...
03 Dec 2012
The New Zealand arm of the Global Poverty Project will be launching a number of new and exciting initiatives in 2013 centred around the worldwide elimination of polio. Their aim is to increase public engagement in The End of Polio campaign and celebrate the phenomenal efforts of Rotary, UNICEF and others. Details of events will be available on...
19 Nov 2012
GAVI is a unique public-private global health partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisations in developing countries. Since 2001 they have helped to vaccinate 370 million children in the world’s poorest countries, helping to prevent more than 5.5 million deaths in the future....
07 Oct 2012
The injectable steroid medication possibly associated with this outbreak of meningitis is not available in New Zealand. Fungal meningitis is not contagious. It can occur when the protective membranes that cover the brain and spinal cord are infected with a fungus normally found in the environment. The fungus can be introduced into the body through...
04 Oct 2012
These data support a recent regulatory submission to expand the indication of Prevenar 13® in the European Union to include adults between 18 and 49 years old, and will be used to support similar planned submissions in other countries around the world in the future. The primary objective of this study was to demonstrate that the immune response to...
24 Sep 2012
The Health Protection Agency of the UK conducted laboratory testing and compared the sequencing of the virus isolate from the 49 year old Qatari national with information on a virus sequenced previously and obtained from a 60 year-old Saudi national who died following infection with a novel coronavirus. This comparison indicated 99.5% identity,...
12 Sep 2012
Auckland Regional Public Health Service (ARPHS) is currently tracing contacts of a person with confirmed measles who arrived in Auckland from Niue on 8 September 2012 and spent some time at Middlemore Emergency Department on 9 September 2012.  We are in the process of writing to all potential contacts. Health professionals are asked to consider...
04 Aug 2012
This is cause for concern given that 70% of adults report that health-related information on the internet influences their health decisions or actions and 59% Americans used internet health information to make decisions for their children. The researchers selected the topic of safe infant sleep and using 13 key phrases analysed advice found on...
03 Aug 2012
Not surprisingly they identified that children who received the whole-cell vaccine were less likely to get whooping cough. A number of factors could contribute to the results of this study: Technology that tests for pertussis infection has improved significantly since the whole-cell vaccine was used in Australia, and New Zealand, and an...
25 Jul 2012
Once the programme is up and running a nasal spray influenza vaccine will be offered to all children aged two to around 17 years. The nasal influenza vaccine has been available for around a decade in America and has an excellent safety profile. The children vaccinated will receive extra protection but the biggest benefit will be protecting very...
12 Jul 2012
Boys in year 9 will also be eligible for the vaccine through a school-based catch-up programme. The vaccine covers two types of human papillomavirus (HPV) that cause genital warts and two types that can cause chronic HPV infection and increase the risk of penile, anal and oropharyngeal cancers in men. Australia has recorded a decrease pre-...
12 Jul 2012
Although extending HPV immunisation to boys is expected to cost A$21.1 million over four years the Pharmaceutical Benefits Advisory Committee recommended the move after a review of its cost effectiveness. Immunising boys against HPV infection will protect them against developing a range of cancers and bolster the effectiveness of this vaccine in...
21 Jun 2012
This is a precautionary recall as checks of the air quality at the vaccines manufacturing site found a problem and sanofi-aventis cannot be completely confident that the vaccine is sterile. The recall notice is available on the Medsafe website. The vaccine is also being recalled in other countries, including Australia and Canada. The BCG Vaccine (...
11 Jun 2012
The Institute of Environmental Science & Research Limited (ESR) monitors the voluntary provision of sexually transmitted infection data and prepares an annual report examining infection trends over time. The Sexually transmitted infections in New Zealand 2011 Surveillance Report identified decreasing numbers of new genital warts cases between...
24 May 2012
Explaining the principle behind this vaccine Institute Director Professor Graham Le Gros said “We don’t know why the immune systems of individuals with asthma or food allergy respond to house dust mites and food proteins as though they were parasites. But what we do know from our research is that if we shut down the Th2 immune response before it...
21 May 2012
Dr Mills used advanced molecular techniques to identify and study the actual bacteria causing middle ear infections in New Zealand children. Instead of having to rely on old New Zealand information or Australian and European data when prescribing antibiotics doctors will be able to make desisions on 'real life' information. The research also ...
26 Mar 2012
Rotvairus “gastro” is a life-threatening diarrheal disease that results in the death of over half a million children under five worldwide and two million hospitalisations each year. In New Zealand, rotavirus is responsible for 1500 hospital admissions of children under five years of age each year. The research collaboration led by the Murdoch...
22 Mar 2012
Australia has been experiencing epidemic levels of pertussis (whooping cough) since 2008 despite high levels of immunisation. However, deaths from the disease are lower than before immunisation against the disease was introduced. Research into the strains of pertussis bacteria causing the disease in Australia between 2008-2010 has been published...
01 Mar 2012
Although New Zealand estimates of childhood immunisation coverage are only currently available to 30 September 2011, three months behind Australia, they have been included in the table below to allow some comparison of immunisation coverage between the two countries. Immunisation coverage figures represent the number of children aged one, two and...
29 Feb 2012
Two types of influenza viruses cause illness and death in people: influenza A and B. Flu vaccines may be inactive injected or live inhaled vaccines. Both types are available in the U.S. but only inactive injected flu vaccines are available in New Zealand. Prior to the safe and successful development and testing of FluMist Quadrivalent seasonal flu...
15 Feb 2012
The vaccine is used to reduce the risk of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in young children and now older adults. In New Zealand Prevenar 13® is recommended for children with conditions that increase their risk of invasive pneumococcal disease and an...
13 Feb 2012
Air New Zealand Flight NZ90 from Toyko arrived at Auckland Airport at 9.21am this morning with a group of unwell Japanese students.  The first passengers were disembarked from the plane at approximately 10.55am.   The medical team at Auckland Regional Public Health worked with Auckland Airport, Air New Zealand, the Ministry of Health and other...
24 Jan 2012
Vaccines for meningococcal groups A, C, Y and W135 are already available but due to the unique nature of the meningococcal B bacteria a vaccine against it has been difficult to develop.   Chilean-led researchers have trialled the 4CMenB vaccine, also known as Bexsero, in infants, toddlers and adolescents and shown the vaccine to be safe and...
06 Jan 2012
In randomised, multi-center studies in the United States and Europe, adults aged 50 and older received either Prevenar 13®, which contains 13 different serotypes of the bacterium Streptococcus pneumonia or Pneumovax® 23, the pneumococcal polysaccharide vaccines which conatins 23 different serotypes of the bacterium. The studies showed that for the...